WUXI XDC (02268.HK) +1.400 (+2.622%) Short selling $49.17M; Ratio 26.470% announced that it resolved to utilize internal funds of up to US$100 million for the professional trustee appointed by the Company in respect of the share schemes of the Company from time to time to purchase the Shares in the open market at the prevailing market price. The Company believed that the current trading price of the Shares does not reflect their intrinsic value or the actual business prospects of the Company, which represents a good opportunity for the Company to conduct the Proposed Share Purchase.Related News JPM: NRDL Adjustment to Accelerate Commercialization of Innovative Drugs; Top Picks INNOVENT BIO (01801.HK), WUXI APPTEC (02359.HK), WUXI XDC (02268.HK), SKB BIO (06990.HK)WUXI XDC opened 2.15% higher this morning at HKD54.55, with 19,600 shares traded in the pre-market session, involving HKD1.07 million.(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-19 12:25.)
AASTOCKS Financial News